Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma

Clinical trial NCT06517888 · RECRUITING

Trial details

NCT number: NCT06517888
Sponsor: Akouos, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Vestibular Schwannoma

Start date: 2025-01-17
Primary completion: 2029-08-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.